Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for ITOXI Corp. (052770:KRX), powered by AI.
ITOXI Corp. is currently trading at ₩312. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for ITOXI Corp. on Alpha Lenz.
ITOXI Corp.'s P/E ratio is -0.2.
“ITOXI Corp. trades at a P/E of -0.2 (undervalued) with modest ROE of -201.2%. 3Y revenue CAGR of 13.8% highlights clear growth momentum.”
Ask for details →Itoxi Corporation is a prominent entity specializing in the production and distribution of chemical products globally. Its core mission is to manufacture high-quality chemical compounds used across various industries, such as pharmaceuticals, agriculture, and manufacturing. Itoxi Corporation is renowned for its commitment to innovation and sustainable practices in chemical production, ensuring its processes minimize environmental impact while maximizing efficiency and effectiveness. The company plays a significant role in sectors that require specialized chemicals, contributing to advancements in medication formulation, crop protection solutions, and materials engineering. By aligning its operations with technological advancements, Itoxi Corporation frequently collaborates with research institutions and industry leaders to stay at the cutting edge. Its global reach extends through a network of facilities and partnerships that allow it to distribute its products efficiently to meet the demands of international markets. Itoxi Corporation's emphasis on quality and reliability makes it a critical player in the global chemical supply chain, ensuring the seamless provision of essential compounds necessary for economic growth and industrial development.
“ITOXI Corp. trades at a P/E of -0.2 (undervalued) with modest ROE of -201.2%. 3Y revenue CAGR of 13.8% highlights clear growth momentum.”
Ask for details →ITOXI Corp. (ticker: 052770) is a company listed on KRX in the Unknown sector (Unknown). Market cap is $4.5B.
The current price is ₩312 with a P/E ratio of -0.21x and P/B of 0.65x.
ROE is -201.21% and operating margin is -68.99%. Annual revenue is $17.2B.